Alzheimer's Disease
Alzheimer's disease is a progressive neurodegenerative disorder that destroys memory and other cognitive functions. It is the most common cause of dementia, accounting for 60-80% of cases. The disease involves accumulation of amyloid plaques and tau tangles in the brain, leading to neuron death.
Prevalence
Approximately 6.7 million Americans age 65 and older have Alzheimer's disease. It is the 7th leading cause of death in the United States. By 2050, the number could reach nearly 13 million.
Who It Affects
Risk increases dramatically with age; most cases occur after age 65. Risk factors include family history, genetics (APOE-e4 gene), cardiovascular risk factors, head injuries, and limited social and cognitive engagement.
Important: This information is for educational purposes only and does not constitute medical advice. Regenerative therapies are investigational and not FDA-approved to treat this condition.
Common Symptoms
Common Causes & Risk Factors
Traditional Treatment Options
Cholinesterase Inhibitors
Medications (donepezil, rivastigmine) that may temporarily improve or stabilize symptoms.
Limitations: Modest effects. Do not stop disease progression. Side effects common.
Memantine
Regulates glutamate activity; used in moderate to severe Alzheimer's.
Limitations: Modest symptomatic benefit. Does not reverse or stop progression.
New Anti-Amyloid Therapies
Recently approved antibodies (lecanemab, aducanumab) that target amyloid plaques.
Limitations: Slow progression modestly in early-stage disease. Significant side effect risk. Expensive with limited availability.
Supportive Care
Cognitive stimulation, physical exercise, occupational therapy, and caregiver support.
Limitations: Helps maintain function and quality of life but cannot stop disease.
Regenerative Medicine Approach
How Regenerative Therapy May Help
Regenerative medicine for Alzheimer's disease is an area of early research exploring whether biologics may have neuroprotective effects or help modulate disease processes. This remains highly experimental with limited clinical data specific to Alzheimer's.
Potential Benefits Being Studied:
- Being studied for potential neuroprotective effects
- Research exploring anti-inflammatory mechanisms
- May help support surviving brain cells (under investigation)
- Very early stage of research for Alzheimer's specifically
- Some preclinical studies showing potential
- Does not replace standard Alzheimer's care
Biologics Used:
Mesenchymal stem cells in early research
Exosomes being studied in laboratory settings
Frequently Asked Questions
Can stem cells cure or reverse Alzheimer's?
No. There is currently no cure for Alzheimer's disease, and no regenerative therapy has been proven to reverse or cure it. Research is ongoing but remains in early stages.
Is this better than the new Alzheimer's drugs?
The new anti-amyloid therapies have undergone rigorous clinical trials and FDA approval processes. Regenerative approaches for Alzheimer's are much earlier in research and cannot be compared to approved treatments.
What should patients and families know?
Be cautious of claims promising Alzheimer's reversal or cure. Current research is preliminary. Focus on proven interventions, clinical trials through reputable centers, and comprehensive support for patients and caregivers.
Ready to Explore Your Options?
Schedule a free consultation to discuss alzheimer's disease and learn if regenerative medicine may be right for you.
Important Disclaimer
Regenerative therapies for Alzheimer's disease are highly investigational with very limited clinical evidence. Beware of exaggerated claims. Consult with a dementia specialist and consider participation in legitimate clinical trials.